🔎 Trials Near Me

Home › Atherosclerosis › Ohio

Pag-aaral pangklinika para sa Atherosclerosis sa Ohio

6 pag-aaral para sa Atherosclerosis ang naghahanap ng mga kalahok sa mga site sa Ohio.

Mga Lungsod sa Ohio

Opisyal na teksto ng pag-aaral (English)

A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis

  • The Christ Hospital, Cincinnati
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07521007

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Velocity Clinical Research, Cincinnati, Springdale, Cincinnati
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07783802

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

  • Velocity Clinical Research, Cincinnati, Mt. Auburn, Cincinnati
  • Velocity Clinical Research, Cleveland, Cleveland
  • Centricity Research Columbus Ohio Multispecialty, Columbus
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT07157774

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  • HNC Dialysis, Ltd., Columbus
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT05485961

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

  • Research Site, Cincinnati
  • Research Site, Columbus
  • Research Site, Lima
  • at 1 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT07000357

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

  • Louis Stokes VA Medical Center, Cleveland, OH, Cleveland
Nagre-recruitPhase 4
Edad 18 pataas · Lahat ng kasarian · Na-update Dis 17, 2025 · NCT02915198

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.